文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Trends in research on nanomedicine in urologic cancer: a bibliometric and visualized analysis.

作者信息

Lan Xiaopeng, Feng Mei, Chen Lili, Zhang Luchen, Han Chao, Wang Yizhen, Zheng Jilu, Wang Xiaoyan, Liu Chunlei, Liu Ranlu

机构信息

Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Department of Urology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266042, People's Republic of China.

出版信息

Discov Oncol. 2024 Aug 23;15(1):366. doi: 10.1007/s12672-024-01249-w.


DOI:10.1007/s12672-024-01249-w
PMID:39179938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11343939/
Abstract

Increasing research efforts are focused on studying the synthesis and mechanisms of nanomedicine in urologic cancer. We performed a bibliometric study of the literature on nanomedicine in urologic cancer over the last 23 years, focusing on aspects such as researchers, institutions, nations, and keywords. We searched for papers in the Web of Science Core Collection from January 1, 2001, to December 29, 2023. Only reviews and original articles written in English were considered. A total of 2386 papers satisfied the given criteria for inclusion. The publications included in the study originated from 90 nations. The United States had the largest number of published papers, accounting for more than 31.01% of the total. The leading institution in this field is the Chinese Academy of Sciences, with a publishing output of 2.35%. Farokhzad, Omid C., is the most prolific author, with 21 articles, and has garnered the most citations, totaling 6271. The latest phrase to enter the top ten most common lists was "gold nanoparticles." We searched for papers in the Web of Science Core Collection from January 1, 2000, to November 28, 2023. Only reviews and original articles written in English were considered. This is the first bibliometric study of nanomedicine in urologic cancer. This article provides a comprehensive analysis of the current state of research on nanomedicine in urologic cancer over the last 23 years. On the basis of this study, future researchers can identify noteworthy publications, journals, and potential collaborators and explore cutting-edge research directions.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/394f50e6bca5/12672_2024_1249_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/ccf9e71af385/12672_2024_1249_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/13bfd79255dc/12672_2024_1249_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/ce10d28c9ccd/12672_2024_1249_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/3a9cde559b4f/12672_2024_1249_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/1619e94691c4/12672_2024_1249_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/799ed9821670/12672_2024_1249_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/394f50e6bca5/12672_2024_1249_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/ccf9e71af385/12672_2024_1249_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/13bfd79255dc/12672_2024_1249_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/ce10d28c9ccd/12672_2024_1249_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/3a9cde559b4f/12672_2024_1249_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/1619e94691c4/12672_2024_1249_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/799ed9821670/12672_2024_1249_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/11343939/394f50e6bca5/12672_2024_1249_Fig7_HTML.jpg

相似文献

[1]
Trends in research on nanomedicine in urologic cancer: a bibliometric and visualized analysis.

Discov Oncol. 2024-8-23

[2]
Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.

Front Biosci (Landmark Ed). 2022-8-31

[3]
Progress and trends in myocardial infarction-related long non-coding RNAs: a bibliometric analysis.

Front Mol Biosci. 2024-7-29

[4]
Mapping Knowledge Landscapes and Emerging Trends of the Links Between Frailty and Heart Failure: A Bibliometric Analysis From 2000 to 2023.

Cureus. 2024-5-17

[5]
Bibliometric and visualized analysis of cancer nanomedicine from 2013 to 2023.

Drug Deliv Transl Res. 2024-6

[6]
Trends of mitochondrial changes in AD: a bibliometric study.

Front Aging Neurosci. 2023-5-16

[7]
[Visual analysis of the current research status and hotspots of electric burns at home and abroad].

Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023-10-20

[8]
Global research trends of infantile hemangioma: A bibliometric and visualization analysis from 2000 to 2022.

Heliyon. 2023-10-21

[9]
Research hotspots and trend analysis of cell transplantation in traumatic spinal cord injury: a bibliometric and visualized analysis.

Front Pharmacol. 2023-12-11

[10]
The top 100 most cited articles on mucopolysaccharidoses: a bibliometric analysis.

Front Genet. 2024-4-12

本文引用的文献

[1]
A systematic review of nanocarriers for treatment of urologic cancers.

Urol Oncol. 2024-4

[2]
Accelerating neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Lancet Oncol. 2024-2

[3]
Evolution of hormesis research: a bibliometric analysis.

Arch Toxicol. 2024-2

[4]
Adjuvant therapy for renal cell carcinoma: A systematic review of current landscape and future directions.

Crit Rev Oncol Hematol. 2023-12

[5]
Targeting sex steroid biosynthesis for breast and prostate cancer therapy.

Nat Rev Cancer. 2023-9-8

[6]
Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker Selection.

Eur Urol. 2023-11

[7]
Reports of Plant-Derived Nanoparticles for Prostate Cancer Therapy.

Plants (Basel). 2023-5-3

[8]
Cancer statistics, 2023.

CA Cancer J Clin. 2023-1

[9]
Nanomedicine for renal cell carcinoma: imaging, treatment and beyond.

J Nanobiotechnology. 2023-1-3

[10]
State-of-the-Art Advances of Nanomedicine for Diagnosis and Treatment of Bladder Cancer.

Biosensors (Basel). 2022-9-27

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索